FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 ...
Mena FN5d
FDA Grants Breakthrough Device Designation For Seastar Medical’S Selective Cytopheretic Device For Adults Undergoing Chronic Dialysis
(MENAFN- GlobeNewsWire - Nasdaq) This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical ...
Business Insider5d
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq ...
Morningstar5d
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
“This is our first Breakthrough Device Designation award for the SCD in a chronic indication. We appreciate the FDA’s continued recognition of the SCD’s potential to save lives and improve ...
Stockhouse5d
FDA Grants Breakthrough Device Designation for SeaStar Medical's Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
“This is our first Breakthrough Device Designation award for the SCD in a chronic indication. We appreciate the FDA’s continued recognition of the SCD’s potential to ...
Medindia6d
AWAK’s Portable Dialysis Device Offers New Hope for Kidney Patients
What if kidney dialysis was portable? AWAK Technologies’ wearable PD device enters trials, promising freedom and comfort for end-stage kidney patients.
OncoSil Medical Expands Pancreatic Cancer Treatment in Europe
OncoSil Medical Ltd (AU:OSL) has released an update. OncoSil Medical Ltd has achieved a significant milestone with the successful implantation ...